Bill Sponsor
House Bill 4761
116th Congress(2019-2020)
DHS Opioid Detection Resilience Act of 2019
Became Law
Became Law
Became Public Law 116-254 on Dec 23, 2020
Overview
Text
Introduced
Oct 18, 2019
Latest Action
Dec 23, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4761
Congress
116
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Sponsorship by Party
Republican
Louisiana
Republican
New York
Democrat
New York
Republican
New York
Republican
North Carolina
Republican
Pennsylvania
House Votes (1)
Senate Votes (1)
checkPassed on December 10, 2019
Question
On Motion to Suspend the Rules and Pass
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
655
House Roll Call Votes
Summary

DHS Opioid Detection Resilience Act of 2019

This bill establishes new requirements related to the detection of illicit narcotics at ports of entry.

Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition.

Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.

Text (6)
July 29, 2020
December 10, 2019
December 9, 2019
December 3, 2019
October 18, 2019
Public Record
Record Updated
Jan 11, 2023 1:46:03 PM